| Sabrina Troyer Figueroa, RN | |
|
1310 E Clifton St, Tampa, FL 33604-6866 | |
| (813) 767-9882 | |
| Not Available |
| Full Name | Sabrina Troyer Figueroa |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1310 E Clifton St, Tampa, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013504307 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 1839042 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sabrina Troyer Figueroa, RN 1310 E Clifton St, Tampa, FL 33604-6866 Ph: (813) 767-9882 | Sabrina Troyer Figueroa, RN 1310 E Clifton St, Tampa, FL 33604-6866 Ph: (813) 767-9882 |
News Archive
Small but significant declines in obesity among low-income preschoolers were found in 18 states and the U.S. Virgin Islands from 2008 to 2011.
At the University of Wisconsin-Madison, one of the most powerful magnetic detectors in the world is helping screen high-risk pregnant patients for rare but very serious fetal heart rhythm problems. Thanks to a collaboration with The Medical College of Wisconsin, Milwaukee; Children's Hospital of Wisconsin, Milwaukee; and Hope Children's Hospital, Chicago, the ultrasensitive detector measures magnetic signals coming from the tiny beating hearts of fetuses.
The Committee for Orphan Medical Products (COMP) of the European Medicines Agency (EMEA) has issued a recommendation granting orphan drug status to Proteo's drug candidate Elafin for the treatment of esophagus carcinoma. The orphan drug status will become effective upon ratification of this recommendation by the European Commission.
New evidence-based educational guidelines evaluate the effectiveness of current continuing medical education (CME) practices and provide the first set of recommendations on how those practices need to change in the future.
Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
› Verified 7 days ago
Brandon Holmes, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 12902 Usf Magnolia Dr, Tampa, FL 33612 Phone: 813-745-4673 | |
Samuel Thomas Dawson, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1 Tampa General Cir, Tampa, FL 33606 Phone: 813-844-7000 | |
Catherine Lyvers Conley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 603 S Boulevard, Tampa, FL 33606 Phone: 813-259-1550 Fax: 813-258-1287 | |
Mrs. Joanne Law, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Tampa, FL 33612 Phone: 813-972-2000 | |
Mr. Hermes Oswaldo Vargas, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Tampa, FL 33612 Phone: 813-972-2000 Fax: 813-910-3030 | |
Brittani Marie Roberts, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3100 E Fletcher Ave, Tampa, FL 33613 Phone: 817-971-6000 |